Unknown PHASE1/PHASE2 INTERVENTIONAL 3-arm NCT03024502

Patients With Vulvovaginal Candidiasis (EPP-AFG-VVC)

Randomized Clinical Trial of a Mucoadhesive Gel Containing EPP-AF in Patients Diagnosed With Vulvovaginal Candidiasis

Sponsor: University of Sao Paulo

Interventions Clotrimazole EPP-AF Gel 1% EPP-AF Gel 2%

Updated 8 times since 2017 Last updated: Oct 17, 2018 Started: Jan 30, 2018 Primary completion: Jan 31, 2020 Completion: Jun 30, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Vulvovaginal Candidiasis, this trial is ongoing. The trial is conducted by University of Sao Paulo and has accumulated 8 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE1/PHASE2
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1/PHASE2

Status: Unknown Status → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1_PHASE2
Nov 2020 — Jan 2021 [monthly]

Unknown Status PHASE1_PHASE2

Status: Recruiting → Unknown Status

▶ Show 3 earlier versions

Nov 2018 — Nov 2020 [monthly]

Recruiting PHASE1_PHASE2

Status: Not Yet Recruiting → Recruiting
Jun 2018 — Nov 2018 [monthly]

Not Yet Recruiting PHASE1_PHASE2
Feb 2017 — Jun 2018 [monthly]

Not Yet Recruiting PHASE1_PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Sao Paulo

Data source: University of Sao Paulo

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ribeirão Preto, Brazil